# Erythropoietin in the Prevention of Acute Mountain Sickness

> **NCT01665781** · PHASE4 · COMPLETED · sponsor: **University of Ulsan** · enrollment: 39 (actual)

## Conditions studied

- Acute Mountain Sickness

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT01665781
- **Lead sponsor:** University of Ulsan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2013-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01665781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01665781, "Erythropoietin in the Prevention of Acute Mountain Sickness". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01665781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*